Does Rallies show 13F holders for CHE?

Yes. Rallies tracks hedge fund and 13F ownership data for CHE, including fund names, share counts, latest tracked quarter, and position changes when available.

Is CHE research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CHE. It does not provide personalized investment advice.

CHE (Chemed Corporation) Stock Analysis - Hedge Fund Holdings

Chemed Corporation (CHE) is a publicly traded Healthcare sector company. As of May 21, 2026, CHE trades at $441.61 with a market cap of $5.86B and a P/E ratio of 23.99. CHE moved +0.10% today. Year to date, CHE is +0.83%; over the trailing twelve months it is -24.05%. Its 52-week range spans $365.21 to $623.61. Analyst consensus is neutral with an average price target of $446.50. Rallies surfaces CHE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CHE stock?

Hedge funds tracked by Rallies that own CHE include Bridgewater Associates, Pinebridge Investments, Mangrove Partners, Panagora Asset, and Centerbook Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Chemed Corporation.

CHE Key Metrics

Key financial metrics for CHE
Metric	Value
Price	$441.61
Market Cap	$5.86B
P/E Ratio	23.99
EPS	$18.36
Dividend Yield	0.60%
52-Week High	$623.61
52-Week Low	$365.21
Volume	0
Avg Volume	0
Revenue (TTM)	$2.54B
Net Income	$259.78M
Gross Margin	32.38%

Top Hedge Funds Holding CHE

Bridgewater Associates holds 5.06K shares of CHE, changed -55.12% as of Mar 31, 2026.
Pinebridge Investments holds 3.62K shares of CHE, changed +144.40% as of Jun 30, 2025.
Mangrove Partners holds 1.64K shares of CHE, changed +21.06% as of Mar 31, 2026.
Panagora Asset holds 1.48K shares of CHE, changed +0.00% as of Mar 31, 2025.
Centerbook Partners holds 1.22K shares of CHE, changed +0.00% as of Mar 31, 2026.

Latest CHE News

VITAS Launches Free Mother’s Day Grief Helpline; Chemed Presents May 12 Conference — May 5, 2026
Chemed Raises 2026 EPS Guidance to $24–24.75; Roto-Rooter Margin Drops to 22.5% — May 4, 2026
Chemed slides as Roto-Rooter margin pressure and divestiture talk outweigh raised outlook — Apr 27, 2026
Chemed jumps nearly 10% on Q1 beat, raised 2026 outlook, Roto-Rooter divestiture talk — Apr 26, 2026
Chemed rallies nearly 10% after Q1 beat, higher 2026 outlook, divestiture talk — Apr 25, 2026

Recent CHE Insider Trades

GRACE PATRICK P sold 60 (~$25.55K) on May 8, 2026.
MCNAMARA KEVIN J sold 2.00K (~$842.26K) on May 1, 2026.
MCNAMARA KEVIN J sold 1.50K (~$554.05K) on Mar 27, 2026.

CHE Analyst Consensus

4 analysts cover CHE: 0 strong buy, 1 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $446.50.

Common questions about CHE

Who owns CHE stock?: Hedge funds tracked by Rallies that own CHE include Bridgewater Associates, Pinebridge Investments, Mangrove Partners, Panagora Asset, and Centerbook Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Chemed Corporation.
Does Rallies show 13F holders for CHE?: Yes. Rallies tracks hedge fund and 13F ownership data for CHE, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CHE research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CHE. It does not provide personalized investment advice.